CVR: 42650668
Previous names: NG Leasing ApS
DKK -307,714
Gross profit
Net result: DKK -246,639
No owners listed
CVR · view ownership and management
Director role ended: Thomas Munkhøj Haslev
CVR · 09/10/2025
View the full event history
Scandinavian Pharma Group ApS was a Danish company of the type Anpartsselskab based in København S, founded in 2021. The company was registered under the industry Detailhandel med kosmetikvarer og toiletartikler. The company was previously named NG Leasing ApS. In 2023, the company reported a gross profit of DKK -307,714 and a net result of DKK -246,639. Equity in the 2023 report amounted to DKK -218,716.
Source: annual reports filed with the Danish Business Authority.
Compared to 346 companies in Detailhandel med kosmetikvarer og toiletartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationNo. Scandinavian Pharma Group ApS is registered in the Danish CVR register with the status Dissolved.
Scandinavian Pharma Group ApS was founded on 1 September 2021.
Scandinavian Pharma Group ApS was registered under the industry Detailhandel med kosmetikvarer og toiletartikler (industry code 477500).
In 2023, Scandinavian Pharma Group ApS reported a gross profit of DKK -307,714.
Scandinavian Pharma Group ApS was located at Islands Brygge 108 st. th, 2300 København S.
The CVR number of Scandinavian Pharma Group ApS is 42650668.
Scandinavian Pharma Group ApS was dissolved on May 5, 2026.
As of October 9, 2025, Thomas Munkhøj Haslev has stepped down as liquidator of Scandinavian Pharma Group ApS.
On October 9, 2025, Scandinavian Pharma Group ApS exited liquidation.
As of September 9, 2025, Thomas Munkhøj Haslev is registered as liquidator of Scandinavian Pharma Group ApS.
On September 9, 2025, Scandinavian Pharma Group ApS entered liquidation.
As of August 18, 2025, Helle Aakvist Jensen has stepped down as director of Scandinavian Pharma Group ApS.
As of August 18, 2025, Nick Hielscher Abel has stepped down as adm. dir. of Scandinavian Pharma Group ApS.
As of August 18, 2025, Camilla Rude Bromark has stepped down as director of Scandinavian Pharma Group ApS.
Scandinavian Pharma Group ApS has published its annual report for 2023. Gross profit came to DKK -307,714, and the net result was DKK -246,639.
Scandinavian Pharma Group ApS has published its interim report for the period September 1, 2021 – December 31, 2022.
As of February 16, 2023, Helle Aakvist Jensen is registered as director of Scandinavian Pharma Group ApS.
As of February 16, 2023, Nick Hielscher Abel is registered as adm. dir. of Scandinavian Pharma Group ApS.
As of February 16, 2023, Camilla Rude Bromark is registered as director of Scandinavian Pharma Group ApS.
As of February 15, 2023, Nick Hielscher Abel has stepped down as director of Scandinavian Pharma Group ApS.
On October 1, 2022, the company changed its name from NG Leasing ApS to Scandinavian Pharma Group ApS.
As of September 1, 2021, Nick Hielscher Abel is registered as director of Scandinavian Pharma Group ApS.
Scandinavian Pharma Group ApS was founded on September 1, 2021.
Companies in the same industry and area
CVR 45022390
CVR 26369266
CVR 33863225
CVR 41259523
CVR 45041174
